Straumann Holding AG (STMN) Market-entry and market expansion strategies
MarketResearchReports.Biz adds “Global Straumann Holding AG (STMN) Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Straumann Holding AG (STMN) market and the growth estimates for the forecasted period.
Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company researches, develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in tooth replacement, restoration or prevention of tooth loss. It also provides training, support and other services to dental practitioners, clinics and laboratories worldwide. The company provides products and solutions for both conventional treatment and digital workflows including guided surgery and intra-oral scanning. The company distributes its products, solutions and services directly and also through a network of partners in Europe, the Middle East and Africa; North America; Asia Pacific; and Latin America. Straumann is headquartered in Basel, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1833114
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Straumann Holding AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Request For TOC Report @https://www.marketresearchreports.biz/reports/1833114/straumann-holding-ag-stmn-product-pipeline-analysis-2018-update-market-research-reports/toc
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Straumann Holding AG Company Overview 5
Straumann Holding AG Company Snapshot 5
Straumann Holding AG Pipeline Products and Ongoing Clinical Trials Overview 5
Straumann Holding AG Pipeline Analysis Overview 8
Business Description 8
Straumann Holding AG - Key Facts 8
Straumann Holding AG - Major Products and Services 9
Straumann Holding AG Pipeline Products by Development Stage 12
Straumann Holding AG Ongoing Clinical Trials by Trial Status 14
Straumann Holding AG Pipeline Products Overview 16
Bone Level Implant System 16
Bone Level Implant System Product Overview 16
Bone Level Implant System Clinical Trial 17
Colored Prosthetics 18
Colored Prosthetics Product Overview 18
Enhanced Bone Graft 19
Enhanced Bone Graft Product Overview 19
Integrated Workflow 20
Integrated Workflow Product Overview 20
Mini-Implant 21
Mini-Implant Product Overview 21
Modular Surgical Cassette 22
Modular Surgical Cassette Product Overview 22
Pre-milled Abutment Blank 23
Pre-milled Abutment Blank Product Overview 23
ProArch - Full Arch Restoration 24
ProArch - Full Arch Restoration Product Overview 24
Single-Use Instrument 25
Single-Use Instrument Product Overview 25
Soft Tissue Control Implant 26
Soft Tissue Control Implant Product Overview 26
Two-Piece Ceramic Implant 27
Two-Piece Ceramic Implant Product Overview 27
Variobase For Bridge/Bar - Full arch 28
Variobase For Bridge/Bar - Full arch Product Overview 28
Straumann Holding AG - Key Competitors 29
Straumann Holding AG - Key Employees 30
Straumann Holding AG - Key Employee Biographies 31
Straumann Holding AG - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Affiliate 34
Recent Developments 35
Straumann Holding AG, Recent Developments 35
Apr 26, 2018: Strong Growth Continues as Straumann Posts 15% Rise in Organic Revenue in Q1 35
Feb 15, 2018: Straumann Group Revenue Exceeds CHF 1bn, Rising 21% (16% organic), while Operating Margin Expands to 26% 37
Oct 26, 2017: Straumann Group raises full-year revenue outlook as organic growth reaches 15% in first nine months 40
Sep 29, 2017: Straumann receives Best Company prize at the 2017 European Digital Communication Awards 43
Aug 17, 2017: Straumann Group posts H1 revenue growth of 14% with further margin improvement 43
Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1 47
Mar 24, 2017: Court in Cologne issues preliminary injunction against MegaGen at the International Dental Show 49
Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne 50
Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development 53
Mar 08, 2017: Straumann complements its all-in-one solutions with 3Shape scanners and Rapid Shape 3D printers 53
Appendix 55
Methodology 55
About GlobalData 57
Contact Us 57
Disclaimer 58
Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company researches, develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in tooth replacement, restoration or prevention of tooth loss. It also provides training, support and other services to dental practitioners, clinics and laboratories worldwide. The company provides products and solutions for both conventional treatment and digital workflows including guided surgery and intra-oral scanning. The company distributes its products, solutions and services directly and also through a network of partners in Europe, the Middle East and Africa; North America; Asia Pacific; and Latin America. Straumann is headquartered in Basel, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1833114
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Straumann Holding AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Request For TOC Report @https://www.marketresearchreports.biz/reports/1833114/straumann-holding-ag-stmn-product-pipeline-analysis-2018-update-market-research-reports/toc
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Straumann Holding AG Company Overview 5
Straumann Holding AG Company Snapshot 5
Straumann Holding AG Pipeline Products and Ongoing Clinical Trials Overview 5
Straumann Holding AG Pipeline Analysis Overview 8
Business Description 8
Straumann Holding AG - Key Facts 8
Straumann Holding AG - Major Products and Services 9
Straumann Holding AG Pipeline Products by Development Stage 12
Straumann Holding AG Ongoing Clinical Trials by Trial Status 14
Straumann Holding AG Pipeline Products Overview 16
Bone Level Implant System 16
Bone Level Implant System Product Overview 16
Bone Level Implant System Clinical Trial 17
Colored Prosthetics 18
Colored Prosthetics Product Overview 18
Enhanced Bone Graft 19
Enhanced Bone Graft Product Overview 19
Integrated Workflow 20
Integrated Workflow Product Overview 20
Mini-Implant 21
Mini-Implant Product Overview 21
Modular Surgical Cassette 22
Modular Surgical Cassette Product Overview 22
Pre-milled Abutment Blank 23
Pre-milled Abutment Blank Product Overview 23
ProArch - Full Arch Restoration 24
ProArch - Full Arch Restoration Product Overview 24
Single-Use Instrument 25
Single-Use Instrument Product Overview 25
Soft Tissue Control Implant 26
Soft Tissue Control Implant Product Overview 26
Two-Piece Ceramic Implant 27
Two-Piece Ceramic Implant Product Overview 27
Variobase For Bridge/Bar - Full arch 28
Variobase For Bridge/Bar - Full arch Product Overview 28
Straumann Holding AG - Key Competitors 29
Straumann Holding AG - Key Employees 30
Straumann Holding AG - Key Employee Biographies 31
Straumann Holding AG - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Affiliate 34
Recent Developments 35
Straumann Holding AG, Recent Developments 35
Apr 26, 2018: Strong Growth Continues as Straumann Posts 15% Rise in Organic Revenue in Q1 35
Feb 15, 2018: Straumann Group Revenue Exceeds CHF 1bn, Rising 21% (16% organic), while Operating Margin Expands to 26% 37
Oct 26, 2017: Straumann Group raises full-year revenue outlook as organic growth reaches 15% in first nine months 40
Sep 29, 2017: Straumann receives Best Company prize at the 2017 European Digital Communication Awards 43
Aug 17, 2017: Straumann Group posts H1 revenue growth of 14% with further margin improvement 43
Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1 47
Mar 24, 2017: Court in Cologne issues preliminary injunction against MegaGen at the International Dental Show 49
Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne 50
Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development 53
Mar 08, 2017: Straumann complements its all-in-one solutions with 3Shape scanners and Rapid Shape 3D printers 53
Appendix 55
Methodology 55
About GlobalData 57
Contact Us 57
Disclaimer 58
Comments
Post a Comment